Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally

Clinical trial NCT00489931 · COMPLETED

Trial details

NCT number: NCT00489931
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza A Virus, H5N1 Subtype Influenza A Virus Influenzavirus A Orthomyxovirdae H5N1 Virus

Start date: 2007-06-18
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.